doi: 10.1038/onc.2011.384 2 MuggiaFMBonettiAHoescheleJDRozencweigMHowellSB
Strategies to optimize your intake The take-home message is quality, dose and delivery form, and duration matter, and they matter a lot
By 2024, an estimated 12% of American adults reported taking a GLP-1 medication for diabetes, weight loss, or heart disease, according to data from the Kaiser Family Foundation
These therapies differ by active ingredient, delivery method, dosing frequency, and FDA-approved indication
Many of the effects of DPP-4 inhibitors in large-scale clinical trials, including their effects on atherosclerotic ischemic events, heart failure, sodium excretion, albuminuria and glomerular function may be meaningfully influenced by their actions to enhance of the endogenous stem-cell chemokine, SDF-1